Dermatomiose Juvenil: Relato De Caso

Autores

  • Kiane Christie da Silveira Hospital Universitário São Francisco na Providência de Deus – HUSF. Bragança Paulista, SP
  • Priscilla Guerra Moura Hospital Universitário São Francisco na Providência de Deus – HUSF. Bragança Paulista, SP

DOI:

https://doi.org/10.37497/JMRReview.v1i1.13

Palavras-chave:

Dermatomiose Juvenil, Miopatia, Pediatria

Resumo

Introdução: A dermatomiose juvenil (DMJ) é uma doença rara, embora seja a miopatia inflamatória mais comum da infância. O início precoce da terapia demonstrou diminuir consideravelmente a morbidade e a mortalidade da doença. Devido à raridade da DMJ, descrever novos casos se torna de grande valia para o processo de educação médica continuada em Pediatria. Objetivo: Relatar um caso único de DMJ atendido em nosso Serviço.

Relato de Caso: Tratou-se de um paciente com histórico de atraso no desenvolvimento motor, que deu entrada em nosso Serviço com dois anos de idade devido a um quadro de fratura do fêmur esquerdo. Após primeira internação, prosseguiu com seguimento em ambulatórios de diversas especialidades, em uma tentativa de investigação multidisciplinar de seu quadro. Posteriormente, foi novamente admitido com quadro de febre e dor em membro superior direito. Durante seguimento com o reumatologista, observou-se que o paciente apresentava manifestações características da DMJ, como rash malar fotossensível, heliotropos e pápulas de Gottron. Posteriormente, iniciou tratamento com metilprednisolona em pulsoterapia por três dias, além de ciclos de ciclofosfamida, finalizando a terapia com prednisona 2mg/kg/dia. Desde então, o paciente mantém acompanhamento.

Conclusão: A DMJ, apesar de sua habitual raridade, possui sinais característicos como rash malar fotossensível, miopatia proximal, heliotropos e pápulas de Gottron, que devem sempre ser considerados no diagnóstico e tratamento precoces. Além disso, a identificação de anticorpos específicos pode ser útil para o diagnóstico da maioria dos pacientes, e sinais não usuais como a coriorretinopatia podem indicar a presença da doença.

Biografia do Autor

Kiane Christie da Silveira, Hospital Universitário São Francisco na Providência de Deus – HUSF. Bragança Paulista, SP

Serviço de Pediatria. Hospital Universitário São Francisco na Providência de Deus - Bragança Paulista, SP.

Priscilla Guerra Moura, Hospital Universitário São Francisco na Providência de Deus – HUSF. Bragança Paulista, SP

Serviço de Pediatria. Hospital Universitário São Francisco na Providência de Deus - Bragança Paulista, SP.

Referências

AL-MAYOUF, S. M. et al. Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children. Rheumatology International, v. 37, n. 9, p. 1513–1517, set. 2017. DOI: https://doi.org/10.1007/s00296-017-3770-x

BELLUTTI ENDERS, F. et al. Consensus-based recommendations for the management of juvenile dermatomyositis. Annals of the Rheumatic Diseases, v. 76, n. 2, p. 329–340, fev. 2017. DOI: https://doi.org/10.1136/annrheumdis-2016-209247

BOHAN, A.; PETER, J. B. Polymyositis and Dermatomyositis: (First of Two Parts). New England Journal of Medicine, v. 292, n. 7, p. 344–347, 1975a. DOI: https://doi.org/10.1056/NEJM197502132920706

BOHAN, A.; PETER, J. B. Polymyositis and Dermatomyositis: (Second of Two Parts). New England Journal of Medicine, v. 292, n. 8, p. 403–407, 1975b. DOI: https://doi.org/10.1056/NEJM197502202920807

CALLEN, J. P. Dermatomyositis. Lancet (London, England), v. 355, n. 9197, p. 53–57, 1 jan. 2000. DOI: https://doi.org/10.1016/S0140-6736(99)05157-0

CHOI, R. Y. et al. Retinal Manifestations of Juvenile Dermatomyositis: Case Report of Bilateral Diffuse Chorioretinopathy with Paracentral Acute Middle Maculopathy and Review of the Literature. Ocular Immunology and Inflammation, v. 26, n. 6, p. 929–933, 2018. DOI: https://doi.org/10.1080/09273948.2017.1305421

DEAKIN, C. T. et al. Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis. Arthritis & Rheumatology (Hoboken, N.J.), v. 68, n. 11, p. 2806–2816, nov. 2016. DOI: https://doi.org/10.1002/art.39753

FELDMAN, B. M. et al. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet (London, England), v. 371, n. 9631, p. 2201–2212, 28 jun. 2008. DOI: https://doi.org/10.1016/S0140-6736(08)60955-1

FISLER, R. E. et al. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. Journal of the American Academy of Dermatology, v. 47, n. 4, p. 505–511, out. 2002. DOI: https://doi.org/10.1067/mjd.2002.122196

HARRIS-LOVE, M. O. et al. Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis. Rheumatology (Oxford, England), v. 48, n. 2, p. 134–139, fev. 2009. DOI: https://doi.org/10.1093/rheumatology/ken441

IWATA, N. et al. Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan. Modern Rheumatology, v. 29, n. 5, p. 802–807, set. 2019. DOI: https://doi.org/10.1080/14397595.2018.1511025

KWA, M. C.; SILVERBERG, J. I.; ARDALAN, K. Inpatient burden of juvenile dermatomyositis among children in the United States. Pediatric Rheumatology Online Journal, v. 16, n. 1, p. 70, 13 nov. 2018. DOI: https://doi.org/10.1186/s12969-018-0286-1

LADD, P. E. et al. Juvenile dermatomyositis: correlation of MRI at presentation with clinical outcome. AJR. American journal of roentgenology, v. 197, n. 1, p. W153-158, jul. 2011. DOI: https://doi.org/10.2214/AJR.10.5337

LI, D.; TANSLEY, S. L. Juvenile Dermatomyositis-Clinical Phenotypes. Current Rheumatology Reports, v. 21, n. 12, p. 74, 11 dez. 2019. DOI: https://doi.org/10.1007/s11926-019-0871-4

LUNDBERG, I. E. et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Annals of the Rheumatic Diseases, v. 76, n. 12, p. 1955–1964, dez. 2017.

MAMYROVA, G. et al. Environmental factors associated with disease flare in juvenile and adult dermatomyositis. Rheumatology (Oxford, England), v. 56, n. 8, p. 1342–1347, 1 ago. 2017. DOI: https://doi.org/10.1093/rheumatology/kex162

MASSA, M. et al. Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis. Arthritis and Rheumatism, v. 46, n. 11, p. 3015–3025, nov. 2002. DOI: https://doi.org/10.1002/art.10566

MENDEZ, E. P. et al. US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis and Rheumatism, v. 49, n. 3, p. 300–305, 15 jun. 2003. DOI: https://doi.org/10.1002/art.11122

MUSSA, F.; NALITOLELA, N.; FREDRICK, F. An 8-year-old-girl with juvenile dermatomyositis and autoimmune thyroiditis in Tanzania: a case report. Journal of Medical Case Reports, v. 15, n. 1, p. 632, 27 dez. 2021. DOI: https://doi.org/10.1186/s13256-021-03222-5

NA, S.-J. et al. Clinical characteristics and outcomes of juvenile and adult dermatomyositis. Journal of Korean Medical Science, v. 24, n. 4, p. 715–721, ago. 2009. DOI: https://doi.org/10.3346/jkms.2009.24.4.715

NAIM, M. Y.; REED, A. M. Enzyme elevation in patients with juvenile dermatomyositis and steroid myopathy. The Journal of Rheumatology, v. 33, n. 7, p. 1392–1394, jul. 2006.

OYEDEJI, O. A. et al. Juvenile Dermatomyositis in an 11 Year Old Nigerian-Boy: A Case Report and Review of Literature. Nigerian Medical Journal: Journal of the Nigeria Medical Association, v. 61, n. 5, p. 284–287, out. 2020. DOI: https://doi.org/10.4103/nmj.NMJ_128_18

PAPADOPOULOU, C.; MCCANN, L. J. The Vasculopathy of Juvenile Dermatomyositis. Frontiers in Pediatrics, v. 6, p. 284, 2018. DOI: https://doi.org/10.3389/fped.2018.00284

REED, A. M.; PACHMAN, L.; OBER, C. Molecular genetic studies of major histocompatibility complex genes in children with Juvenile dermatomyositis: Increased risk associated with HLA-DQA1∗0501. Human Immunology, v. 32, n. 4, p. 235–240, 1 dez. 1991. DOI: https://doi.org/10.1016/0198-8859(91)90085-N

RIDER, L. G. et al. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine, v. 92, n. 4, p. 223–243, jul. 2013. DOI: https://doi.org/10.1097/MD.0b013e31829d08f9

RIDER, L. G.; NISTALA, K. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes. Journal of Internal Medicine, v. 280, n. 1, p. 24–38, jul. 2016. DOI: https://doi.org/10.1111/joim.12444

ROSA NETO, N. S.; GOLDENSTEIN-SCHAINBERG, C. Dermatomiosite juvenil: revisão e atualização em patogênese e tratamento. Revista Brasileira de Reumatologia, v. 50, p. 299–312, jun. 2010. DOI: https://doi.org/10.1590/S0482-50042010000300010

SCHMIDT, J. Current Classification and Management of Inflammatory Myopathies. Journal of Neuromuscular Diseases, v. 5, n. 2, p. 109–129, 2018. DOI: https://doi.org/10.3233/JND-180308

SPENCER, C. H. et al. Course of treated juvenile dermatomyositis. The Journal of Pediatrics, v. 105, n. 3, p. 399–408, set. 1984. DOI: https://doi.org/10.1016/S0022-3476(84)80012-8

STRINGER, E.; FELDMAN, B. M. Advances in the treatment of juvenile dermatomyositis. Current Opinion in Rheumatology, v. 18, n. 5, p. 503–506, set. 2006. DOI: https://doi.org/10.1097/01.bor.0000240362.32089.4c

STRINGER, E.; SINGH-GREWAL, D.; FELDMAN, B. M. Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features. Arthritis and Rheumatism, v. 58, n. 11, p. 3585–3592, nov. 2008. DOI: https://doi.org/10.1002/art.23960

SWAFFORD, C.; ROACH, E. S. Juvenile Dermatomyositis and the Inflammatory Myopathies. Seminars in Neurology, v. 40, n. 3, p. 342–348, jun. 2020. DOI: https://doi.org/10.1055/s-0040-1705120

SYMMONS, D. P.; SILLS, J. A.; DAVIS, S. M. The incidence of juvenile dermatomyositis: results from a nation-wide study. British Journal of Rheumatology, v. 34, n. 8, p. 732–736, ago. 1995. DOI: https://doi.org/10.1093/rheumatology/34.8.732

TANSLEY, S. L. et al. Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort. Journal of Autoimmunity, v. 84, p. 55–64, nov. 2017. DOI: https://doi.org/10.1016/j.jaut.2017.06.007

UKICHI, T. et al. MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis. RMD open, v. 5, n. 1, p. e000850, 2019. DOI: https://doi.org/10.1136/rmdopen-2018-000850

VOLOCHAYEV, R. et al. Laboratory Test Abnormalities are Common in Polymyositis and Dermatomyositis and Differ Among Clinical and Demographic Groups. The Open Rheumatology Journal, v. 6, p. 54–63, 2012. DOI: https://doi.org/10.2174/1874312901206010054

WIENKE, J. et al. Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools. Frontiers in Immunology, v. 9, p. 2951, 2018. DOI: https://doi.org/10.3389/fimmu.2018.02951

Downloads

Publicado

2022-11-22

Como Citar

Silveira, K. C. da, & Moura, P. G. (2022). Dermatomiose Juvenil: Relato De Caso. Journal of Medical Residency Review, 1(1), e013. https://doi.org/10.37497/JMRReview.v1i1.13

Edição

Seção

Artigos